Ai® (Influenza A/B Typing Rapid Diagnostic Test)
PCL’s SG Cap™ technology and multiplexing capabilities make it possible to simultaneously detect both A and B-type influenza viruses. PCL has developed a POCT test with >90% sensitivity and specificity that produces a diagnostic result within 30 minutes. PCL will soon provide an expanded line of POCT products for other pathogens that cause respiratory infections.
◆ Characteristics
Product name | Ai® (Influenza A/B Typing Rapid Diagnostic Test) |
---|---|
Manufacturer | PCL Inc. |
Category | Multiplex antigen detection kit |
Specificity | >99.5% |
Sensitivity | Influenza A (>90.0%), Influenza B (>90.0%) |
Specimen | Nasopharyngeal & Throat Secretion |
Immobilized material | Influenza A/B antibodies |
Target material | Influenza A/B antigens |
Assay method | Immunofluorescence |
Volume of specimen | 50ul |
Assay time | <30 min |